Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.

Martínez V, Navarro C, Cano C, Fajardo W, Blanco A.

Artif Intell Med. 2015 Jan;63(1):41-9. doi: 10.1016/j.artmed.2014.11.003. Epub 2015 Jan 13.

PMID:
25704113
2.

ProphNet: a generic prioritization method through propagation of information.

Martínez V, Cano C, Blanco A.

BMC Bioinformatics. 2014;15 Suppl 1:S5. doi: 10.1186/1471-2105-15-S1-S5. Epub 2014 Jan 10.

3.

Integrating Biological Networks for Drug Target Prediction and Prioritization.

Ji X, Freudenberg JM, Agarwal P.

Methods Mol Biol. 2019;1903:203-218. doi: 10.1007/978-1-4939-8955-3_12.

PMID:
30547444
4.

Network-based inference methods for drug repositioning.

Chen H, Zhang H, Zhang Z, Cao Y, Tang W.

Comput Math Methods Med. 2015;2015:130620. doi: 10.1155/2015/130620. Epub 2015 Apr 12.

5.

Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.

Re M, Valentini G.

IEEE/ACM Trans Comput Biol Bioinform. 2013 Nov-Dec;10(6):1359-71. doi: 10.1109/TCBB.2013.62.

6.

Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.

Lotfi Shahreza M, Ghadiri N, Green JR.

Methods Mol Biol. 2019;1903:291-316. doi: 10.1007/978-1-4939-8955-3_18.

PMID:
30547450
7.

Drug target prediction and repositioning using an integrated network-based approach.

Emig D, Ivliev A, Pustovalova O, Lancashire L, Bureeva S, Nikolsky Y, Bessarabova M.

PLoS One. 2013 Apr 4;8(4):e60618. doi: 10.1371/journal.pone.0060618. Print 2013.

8.

Computational drug repositioning through heterogeneous network clustering.

Wu C, Gudivada RC, Aronow BJ, Jegga AG.

BMC Syst Biol. 2013;7 Suppl 5:S6. doi: 10.1186/1752-0509-7-S5-S6. Epub 2013 Dec 9.

9.

ProphTools: general prioritization tools for heterogeneous biological networks.

Navarro C, Martínez V, Blanco A, Cano C.

Gigascience. 2017 Dec 1;6(12):1-8. doi: 10.1093/gigascience/gix111.

10.

Network mirroring for drug repositioning.

Park S, Lee DG, Shin H.

BMC Med Inform Decis Mak. 2017 May 18;17(Suppl 1):55. doi: 10.1186/s12911-017-0449-x.

11.

Drug repositioning using drug-disease vectors based on an integrated network.

Lee T, Yoon Y.

BMC Bioinformatics. 2018 Nov 21;19(1):446. doi: 10.1186/s12859-018-2490-x.

12.

Drug repositioning by integrating target information through a heterogeneous network model.

Wang W, Yang S, Zhang X, Li J.

Bioinformatics. 2014 Oct 15;30(20):2923-30. doi: 10.1093/bioinformatics/btu403. Epub 2014 Jun 27.

13.

MD-Miner: a network-based approach for personalized drug repositioning.

Wu H, Miller E, Wijegunawardana D, Regan K, Payne PRO, Li F.

BMC Syst Biol. 2017 Oct 3;11(Suppl 5):86. doi: 10.1186/s12918-017-0462-9.

14.

Interactogeneous: disease gene prioritization using heterogeneous networks and full topology scores.

Gonçalves JP, Francisco AP, Moreau Y, Madeira SC.

PLoS One. 2012;7(11):e49634. doi: 10.1371/journal.pone.0049634. Epub 2012 Nov 19.

15.

Disease gene prioritization by integrating tissue-specific molecular networks using a robust multi-network model.

Ni J, Koyuturk M, Tong H, Haines J, Xu R, Zhang X.

BMC Bioinformatics. 2016 Nov 10;17(1):453.

16.

ksRepo: a generalized platform for computational drug repositioning.

Brown AS, Kong SW, Kohane IS, Patel CJ.

BMC Bioinformatics. 2016 Feb 9;17:78. doi: 10.1186/s12859-016-0931-y.

17.

Pathway-based drug repositioning using causal inference.

Li J, Lu Z.

BMC Bioinformatics. 2013;14 Suppl 16:S3. doi: 10.1186/1471-2105-14-S16-S3. Epub 2013 Oct 22.

18.

A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.

Rakshit H, Chatterjee P, Roy D.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):280-7. doi: 10.1016/j.bbrc.2014.12.101. Epub 2015 Jan 7.

PMID:
25576361
19.

Computational drug repositioning using meta-path-based semantic network analysis.

Tian Z, Teng Z, Cheng S, Guo M.

BMC Syst Biol. 2018 Dec 31;12(Suppl 9):134. doi: 10.1186/s12918-018-0658-7.

20.

Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.

Cheng F, Li W, Wu Z, Wang X, Zhang C, Li J, Liu G, Tang Y.

J Chem Inf Model. 2013 Apr 22;53(4):753-62. doi: 10.1021/ci400010x. Epub 2013 Apr 8.

PMID:
23527559

Supplemental Content

Support Center